Here we report the derivation of a monoclonal antibody specific for mouse NKG2D. We have been able to definitively identify the cell types expressing the receptor in mice and address two important questions regarding NK cell function: the contribution of the NKG2D receptor in natural killing of tumor cells and the capacity of the receptor to directly stimulate various NKG2D ϩ cell types. Figure 1C) . study NKG2D induction in vivo, B6 mice were infected with lymphocytic choriomeningitis virus (LCMV), and anFreshly isolated CD8 ϩ and CD4 ϩ splenic ␣␤ T cells from nonimmune mice did not stain with MI-6 mAb, tigen-specific CD8 ϩ T cell populations were examined using fluorochrome-conjugated MHC class I tetramers confirming previous findings that naive T cells in mice do not express NKG2D (Figure 2A ) (Diefenbach et al., loaded with viral epitopes. At the peak of the immune response (day 9), nearly all CD8 ϩ T cells specific for the 2000). After activation in vitro with plate-bound anti-TCR antibody, NKG2D expression was detectable on GP33 or NP396 viral peptides had upregulated NKG2D ( Figure 2C , and data not shown). An interesting finding the surface of CD8 ϩ T cells within 2 days (Figure 2A ). The levels continued to increase, reaching high uniform was that NKG2D expression remained high on virusspecific memory T cells even 8 months after infection levels by the fifth day of activation. The unimodal staining pattern indicated that NKG2D was upregulated in and was retained on the virus-specific T cells responding to a secondary infection. NKG2D expression CD8 ϩ T cells that did not previously express it. In con-was also induced on many CD8 ϩ T cells that did not stain with these two tetramers. Most of these cells are probably specific for other viral epitopes, though some may represent "bystander" CD8 ϩ T cells that are partially activated during LCMV infection.
Results

NKG2D Expression Pattern
To examine NKG2D expression by macrophages, we employed F(abЈ) 2 fragments of MI-6 mAb to prevent interactions with Fc receptors. MI-6 F(abЈ) 2 failed to stain bone marrow-derived macrophages that had been cultured for 1-3 days in medium alone or with the addition of TNF␣ ( Figure 3A) . However, macrophages that had been cultured for 1-3 days in the presence of LPS, IFN-␥, or IFN-␣/␤ exhibited clear staining with MI-6 F(abЈ) 2 , as compared to control polyclonal rat F(abЈ) 2 ( Figure 3A) . Staining was completely blocked if the MI-6 F(abЈ) 2 were preincubated with recombinant NKG2D protein. Surface expression of NKG2D was detectable after 1 day in culture and increased on days 2 and 3 of stimulation. Similar results were seen for macrophages isolated from the peritoneum after thioglycollate induction (data not shown). Accordingly, Northern blot analysis revealed that NKG2D mRNA was absent in bone marrow-derived macrophages that had been cultured with TNF␣ or no addition, but was clearly detectable in macrophages that had been cultured with LPS, IFN-␥, or especially IFN-␣/␤ ( Figure 3B ).
Cross-Linking of NKG2D with MI-6 mAb Activates NK Cells and Macrophages, but Not CD8
؉ T Cells The capacity of MI-6 mAb to stimulate NKG2D ϩ cells was assessed. The addition of MI-6 mAb to FcR ϩ Daudi target cells enhanced lysis of these cells by LAK cells, suggesting that the antibody mediates redirected lysis when bridged to a target cell ( Figure 4A ). Although these data are consistent with direct stimulation of NK cells by NKG2D, it remained possible that additional receptor/ ligand interactions between the NK cell and the target cell were necessary for realization of MI-6-mediated cytotoxicity.
To investigate whether NKG2D engagement alone im- control rat IgG or the nonstimulatory DX5 mAb had no effect ( Figure 4B , and data not shown). These data suggest that NKG2D cross-linking leads to Ca 2ϩ mobili-‫01ف‬ g/ml ( Figure 4C ). Control F(abЈ) 2 had no effect, even at 40 g/ml. A similar response to MI-6 mAb was zation.
For functional analysis of NK cells and macrophages, observed with LAK cells from mutant mice lacking the NK cell Fc receptor (Fc␥RIII Ϫ/Ϫ mice), effectively ruling it was important to avoid the possibility that the MI-6 mAb could engage Fc receptors on the cells, thus imout the possibility that the response was due to residual intact antibody in the F(abЈ) 2 preparation ( Figure 4D ). parting a directly stimulatory signal. Therefore, we employed MI-6 F(abЈ) 2 fragments for these experiments.
The response of LAK cells to MI-6 mAb was similar to the response to PK136, a mAb specific for the stimula-LAK cells or freshly isolated NK cells were stimulated to produce IFN-␥ by plate-bound MI-6 F(abЈ) 2 at coating tory receptor NKR-P1C (Karlhofer and Yokoyama, 1991). Combining PK136 with a limiting dose of MI-6 F(abЈ) 2 doses of 1 g/ml or higher, reaching a maximum with ment. For unknown reasons, the percentage of NK cells that secrete IFN-␥ in response to PK136 or MI-6 generally reached a maximum of 10%-30% in these experiments (Figure 4) , and only 50%-80% of the cells responded even to pharmacologic agents (PMA plus ionomycin) in most experiments (data not shown). A substantial fraction of NK1.1 ϩ CD3 Ϫ cells are therefore generally hyporesponsive to stimulation with these agents, perhaps because they are immature or anergic.
To examine the responses of activated macrophages to receptor stimulation, bone marrow macrophages were precultured alone or with IFN-␣/␤ to induce NKG2D expression and then transferred to wells coated with MI-6 F(abЈ) 2 or control F(abЈ) 2 . Macrophage stimulation was assessed 2 days later in terms of either nitric oxide (NO) production or TNF␣ secretion. NKG2D cross-linking resulted in substantial secretion of nitric oxide and TNF␣, whereas wells coated with control F(abЈ) 2 had no effect ( Figure 4F ). Control macrophages that had been cultured in the absence of IFN-␣/␤, and therefore did not express NKG2D, did not respond to stimulation by MI-6 mAb ( Figure 4F ). The requirement for receptor induction argues against the possibility that macrophage activation was due to LPS or other possible contaminants in the anti-NKG2D antibody preparation. Similar results were obtained with thioglycollate-induced peritoneal macrophages (data not shown). Cross-linking with MI-6 F(abЈ) 2 also enhanced a basal level of NO production that was induced by LPS or IFN-␥ (data not shown).
To investigate whether MI-6 mAb stimulates activated CD8 ϩ T cells, we generated a CD8 ϩ T cell line specific for the LCMV GP33 peptide. These cells expressed uniformly high levels of NKG2D (data not shown). In contrast to the results with NK cells, MI-6 failed to mediate redirected lysis of Daudi target cells by activated CD8 ϩ T cells, suggesting that NKG2D does not directly stimulate CD8 ϩ T cells ( Figure 5A ). Furthermore, the activated 
The NKG2D Receptor Mediates Natural Killing of Tumor Cells
To test the efficacy of MI-6 mAb in functionally blocking enhanced the response only slightly compared to the response to PK136 alone ( Figure 4E) , suggesting that the NKG2D-ligand interaction, we employed two tumor cell lines that do not express NKG2D ligands and com-NKG2D engagement does not provide significant costimulatory activity in conjunction with NKR-P1C engagepared them to retroviral transductants that express high 
